(Q33551013)

28 July 2017

Toward characterization and definition of fibromyalgia severity (English)

1 reference

28 July 2017

0 references

Stuart Silverman

1

1 reference

28 July 2017

Alesia Sadosky

2

1 reference

28 July 2017

Chris Evans

3

1 reference

28 July 2017

Yating Yeh

4

1 reference

28 July 2017

Jose Ma J Alvir

5

1 reference

28 July 2017

Gergana Zlateva

6

1 reference

28 July 2017

8 April 2010

1 reference

BMC Musculoskeletal Disorders

28 July 2017

1 reference

28 July 2017

11

1 reference

28 July 2017

66

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-11-66

28 July 2017

0 references

cites work

Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Patient perspectives on the impact of fibromyalgia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Disability and quality of life in patients with fibromyalgia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Antipolymer antibody in Italian fibromyalgic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Characteristics and healthcare costs of patients with fibromyalgia syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Do different factors explain self-rated health in men and women?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Which of the three different tender points assessment methods is more useful for predicting the severity of fibromyalgia syndrome?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity [...]

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Classification, epidemiology, and natural history of fibromyalgia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

The role of gender in fibromyalgia syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Responsiveness of fibromyalgia clinical trial outcome measures.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

A model to assess severity and impact of fibromyalgia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Gender variations in clinical pain experience

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

The fibromyalgia impact questionnaire: development and validation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Urinary markers of altered collagen metabolism in fibromyalgia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Patient-reported outcomes better discriminate active treatment from placebo in randomized controlled trials in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

A prospective long-term study of fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-66

Cytokine patterns in fibromyalgia and their correlation with clinical manifestations.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2858098

31 October 2018

Fibromyalgia syndrome

1 reference

12 December 2020

Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period

1 reference

12 December 2020

Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome

1 reference

12 December 2020

Health status and disease severity in fibromyalgia. Results of a six-center longitudinal study

1 reference

12 December 2020

Sex differences in pain

1 reference

12 December 2020

An index of patient reported outcomes (PRO-Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis

1 reference

12 December 2020

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2474-11-66

1 reference

Dimensions Publication ID

28 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-11-66

9 September 2019

1 reference

28 July 2017

1 reference